Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis

Annals of the Rheumatic Diseases

Volumn 63, Issue 1, 2004, Pages 78-83

  Lajeunesse, D ^a   Martel Pelletier, J ^a   Fernandes, J C ^a   Laufer, S ^b   Pelletier, J P ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; LEUKOTRIENE B4; LICOFELONE; LIPOXYGENASE INHIBITOR; OSTEOCALCIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; SOMATOMEDIN C; UROKINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; NONHUMAN; OSTEOARTHRITIS; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE;

ACETIC ACIDS; ANIMALS; ANTIRHEUMATIC AGENTS; ARACHIDONATE 5-LIPOXYGENASE; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOGS; ENZYME INHIBITORS; INSULIN-LIKE GROWTH FACTOR I; LEUKOTRIENE B4; OSTEOARTHRITIS; OSTEOBLASTS; PYRROLES; URINARY PLASMINOGEN ACTIVATOR;

EID: 0347320523     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.003624     Document Type: Article

References (45)

1. Pelletier JP, Martel-Pelletier J, Howell DS. Etioparhogenesis of osteoarthritis. In: Koopman WJ, ed. Arthritis and allied conditions. A textbook of rheumatology. Baltimore: Williams & Wilkins, 2001:2195-245.
2. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
3. Martel-Pelletier J, Di Battista JA, Lajeunesse D. Biochemical factors in joint articular tissue degradation in osteoarthritis. In: Reginster JY, Pelletier JP, Martel-Pelletier J, Henrotin Y, eds. Osteoarthritis: clinical and experimental aspects. Berlin: Springer, 1999:156-87.
4. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 1998;41:891-9.
5. Hilal G, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 inhuman osteoarthritic subchondral osteoblasts. Arthritis Rheum 1999;42:2112-22.
6. Mansell JP, Tarlton JF, Bailey AJ. Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol 1997;36:16-19.
7. Mansell JP, Bailey AJ. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 1998;101:1596-603.
8. Li B, Aspden RM. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 1997;12:641-51.
9. Li B, Aspden RM. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997;56:247-54.
10. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 1997;40:1282-91.
11. Brandt KD. Insights into the natural history of osteoarthritis provided by the cruciate-deficient dog. An animal model of osteoarthritis [review]. Ann NY Acad Sci 1994;732:199-205.
12. Dedrick DK, Goldstein SA, Brandt KD, O'Connor BL, Goulet RW, Albrecht M. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months. Arthritis Rheum 1993;36:1460-7.
13. Dedrick DK, Goulet RW, O'Connor BL, Brandt KD. Preliminary report: increased porosity of the subchondral plate in an accelerated canine model of osteoarthritis. Osteoarthritis Cartilage 1997;5:71-4.
14. Brandt KD, Myers SL, Burr D, Albrecht M. Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament. Arthritis Rheum 1991;34:1560-70.
15. Pelletier JP, Lajeunesse D, Jovanovic DV, Lascau-Coman V, Jolicoeur FC, Hilal G, et al. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bane in experimental dog osteoarthritis. J Rheumatol 2000;27:2893-902.
16. Bailey AJ, Sims TJ, Knott L. Phenotypic expression of osteoblast collagen in osteoarthritic bone: production of type I homotrimer. Int J Biochem Cell Biol 2002;34:176-82.
17. Carlson CS, Loeser RF, Purser CB, Gardin JF, Jerome CP. Osteoarthritis in cynomolgus macaques. III: Effects of age, gender, and subchondral bone thickness on the severity of disease, J Bone Miner Res 1996;11:1209-17.
18. Hulth A. Does osteoarthrosis depend on growth of the mineralized layer of cartilage? Clin Orthop 1993;287:19-24.
19. Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KPH. Subchondral bone in osteoarthritis. Calcif Tissue Int 1991;49:20-6.
20. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986;213:34-40.
21. Dequeker J, Mohan R, Finkelman RD, Aerssens J, Baylink DJ. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 1993;36:1702-8.
22. Gevers G, Dequeker J. Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis. Coll Relat Res 1987;7:435-42.
23. Paredes Y, Massicotte F, Pelletier JP, Martel-Pelletier J, Laufer S, Lajeunesse D. Study of role of leukotriene B4 in abnormal function of human subchondral osteoarthritis osteoblasts. Effect of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum 2002;46:1804-12.
24. Massicotte F, Lajeunesse D, Benderdour M, Pelletier J-P, Hilal G, Duval N, et al. Can altered production of interleukin 1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002;10:491-500.
25. Imhof H, Breitenseher M, Kainberger F, Rand T, Trattnig S. Importance of subchondral bone to articular cartilage in health and disease. Top Magn Reson Imaging 1999;10:180-92.
26. Sokoloff L. Microcracks in the calcified layer of articular cartilage. Arch Pathol Lab Med 1993;117:191-5.
27. Mital MA, Millington PF. Osseous pathway of nutrition to articular cartilage of the human femoral head. Lancet 1970;1:842.
28. Pelletier JP, Jovanovic D, Fernandes JC, Manning PT, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
29. Pelletier JP, Di Battista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1 and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995;72:578-86.
30. Jovanovic DV, Fernandes JC, Martel-Pelletier J, Jolicoeur FC, Reboul P, Laufer S, et al. The in vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis. Suppression of collagenase-1 and interleukin-1beta synthesis. Arthritis Rheum 2001;44:2320-30.
31. Pelletier JP, Mineau F, Raynauld JP, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994;37:414-23.
32. Fernandes JC, Martel-Pelletier J, Otterness IG, Lopez-Anaya A, Mineau F, Tardif G, et al. Effects of tenidap on canine experimental osteoarthritis: I. Morphologic and metalloprotease analysis. Arthritis Rheum 1995;38:1290-303.
33. Lajeunesse D, Busque L, Ménard P, Brunette MG, Bonny Y. Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis: correction of the phenotype after bone marrow transplant. J Clin Invest 1996;98:1835-42.
34. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Mineral 1991;14:237-50.
35. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
36. Leprince P, Register B, Moonen G. A colorimetric assay for the simultaneous measurement of plasminogen activators and plasminogen activator inhibitors in serum-free conditioned media from cultured cells. Anal Biochem 1989;177:341-6.
37. Mohan S, Bautista CM, Herring SJ, Linkhart TA, Baylink DJ. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. Endocrinology 1990;126:2534-42.
38. Gundberg CM, Hauschka PV, Lian JB, Gallop PM. Osteocalcin: isolation, characterization and detection. Methods Enzymol 1984;107:516-44.
39. Massicotte F, Martel-Pelletier J, Pelletier J-P, Lajeunesse D. Abnormal modulation of insulin-like growth factor 1 levels in human osteoarthritic bone oesteoblast (abstract). Arthritis Rheum 2000;43(suppl):S206.
40. McCarthy TL, Centrella M, Raisz LG, Canalis E. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1991;128:2895-900.
41. Schouten JS, Van den Ouweland FA, Valkenburg HA, Lamberts SW. Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol 1993;32:274-80.
42. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
43. van den Berg WB. Growth factors in experimental osteoarthritis: transforming growth factor beta pathogenic? J Rheumatol Suppl 1995;43:143-5.
44. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998;6:306-17.
45. Martel-Pelletier J, Hilal G, Pelletier JP, Ranger P, Lajeunesse D. Evidence for increased metabolic activity in human osteoarthritic subchondral bone expiants (abstract). Arthritis Rheum 1997;40(suppl):S182.